Aspectos epidemiológicos e fingerprinting da microbiota do trato respiratório superior: estudo comparativo entre indivíduos comunitários ou hospitalizados com COVID-19 e pacientes comunitários com SRAG por outras etiologias
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
DOI
Abstract
The COVID-19 pandemic, caused by the SARS-CoV-2 virus, has had a significant global
impact, with more than 761 million infections and 6.7 million deaths worldwide. In Brazil, the
health and hospital crisis resulted in the biggest collapse in the country's history. This has
affected the prevalence of other respiratory viruses, but a diverse group of viruses, such as
rhinoviruses, adenoviruses, parainfluenza, metapneumoviruses, and influenza, still cause a
large number of respiratory illnesses. They continue to be a leading cause of acute respiratory
infections, not related to COVID-19. The diagnosis of viral respiratory infections can be based
on clinical symptoms or the etiological agent. Knowledge about the respiratory microbiome is
an area of growing interest in pulmonary medicine, as its diversity and balance have a direct
impact on health and disease. Factors such as type of birth, age, sex, genetic conditions, social
behavior and diet play an important role in the composition of the microbiota. The immune
response to infection is affected by several factors, including intrinsic and extrinsic biological
conditions of the host. Studies show significant sex differences in immune response, with
women generally having stronger responses, developing more robust vaccine responses, and
surviving acute infections better. This study analyzed the structure of the microbiota of
respiratory samples from patients hospitalized due to COVID-19, patients with flu syndrome
from other causes and the influence of sociodemographic and clinical characteristics. The
sample included 118 individuals of both sexes and different ages. The results revealed that the
group of hospitalized COVID-19 patients (G3) had the lowest percentage of flu vaccination and
more comorbidities, while the group with flu syndrome of other etiologies (G1) and the group
with community COVID-19 (G2) had better immunization rates. G1 had the largest number of
healthy individuals. Symptoms varied, with G1 predominantly having respiratory symptoms,
while G2 and G3 had both respiratory and non-respiratory symptoms, with G2 being more
affected. The fingerprint results grouped the patients into two clusters: C1, mostly composed
of hospitalized, elderly and less immunized individuals; and C2, which included young
individuals with and without COVID-19, who were more immunized. In summary, this study
highlighted the importance of considering not only SARS-CoV-2 but other respiratory viruses
in the diagnosis and treatment of respiratory infections. Furthermore, it showed how the
respiratory microbiome and sociodemographic and clinical factors influence the immune
response and the severity of infections. These discoveries can promote more effective strategies
for preventing and treating respiratory diseases, but it is essential to carry out more research to
deepen the understanding of these mechanisms and improve the clinical management of these
diseases.
Description
Citation
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

